| Literature DB >> 26172831 |
Christian Theilacker1, Ann-Kristin Diederich2, Andreas Otto3, Irina G Sava4, Dominique Wobser5, Yinyin Bao5, Katrin Hese6, Melanie Broszat5, Philipp Henneke7, Dörte Becher3, Johannes Huebner8.
Abstract
In this study, we investigated the impact of the cell membrane composition of E. faecalis on its recognition by the host immune system. To this end, we employed an E. faecalis deletion mutant (ΔbgsA) that does not synthesize the major cell membrane glycolipid diglycosyl-diacylglycerol (DGlcDAG). Proteomic analysis revealed that 13 of a total of 21 upregulated surface-associated proteins of E. faecalis ΔbgsA were lipoproteins. This led to a total lipoprotein content in the cell membrane of 35.8% in ΔbgsA compared to only 9.4% in wild-type bacteria. Increased lipoprotein content strongly affected the recognition of ΔbgsA by mouse macrophages in vitro with an increased stimulation of TNF-α production by heat-fixed bacteria and secreted antigens. Inactivation of the prolipoprotein diacylglycerol transferase (lgt) in ΔbgsA abrogated TNF-α induction by a ΔbgsA_lgt double mutant indicating that lipoproteins mediate increased activation of mouse macrophages by ΔbgsA. Heat-fixed ΔbgsA bacteria, culture supernatant, or cell membrane lipid extract activated transfected HEK cells in a TLR2-dependent fashion; the same was not true of wild-type bacteria. In mice infected intraperitoneally with a sublethal dose of E. faecalis we observed a 70% greater mortality in mice infected with ΔbgsA compared with wild-type-infected mice. Increased mortality due to ΔbgsA infection was associated with elevated plasma levels of the inflammatory cytokines TNF-α, IL-6 and MIP-2. In summary, our results provide evidence that an E. faecalis mutant lacking its major bilayer forming glycolipid DGlcDAG upregulates lipoprotein expression leading to increased activation of the host innate immune system and virulence in vivo.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26172831 PMCID: PMC4501811 DOI: 10.1371/journal.pone.0132949
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains used and plasmids used in this study.
| strain or plasmid | characterization | reference |
|---|---|---|
|
| ||
|
| Clinical isolate, strong biofilm producer | [ |
|
| (EF2891) | [ |
|
| (EF2890) | [ |
|
| (EF 1748) | this study |
|
| double | this study |
|
| double | this study |
|
| Gram-negative cloning host | Invitrogen |
|
| Gram-negative cloning host | Invitrogen |
|
| ||
| pCASPER | Gram-positive, temperature-sensitive mutagenesis vector | [ |
| pCRII-TOPO | Gram-negative cloning vector | Invitrogen |
| pCASPER/Δ | pCASPER carrying a | this study |
Primers used in this study.
| name | sequence (5´-3´) | |
|---|---|---|
| 1 | pEF1748delF | CCTTGTTCGAGCCCTTTACTT |
| 2 | pEF1748OEF |
|
| 3 | pEF1748delR | ACGTCATGAACCTGTTTGGAG |
| 4 | pEF1748OER |
|
aLinkers are underlined.
Surface-associated proteins present in significantly different amounts in ΔbgsA compared to the wild-type.
The log2ratio depicts the change of ΔbgsA compared to the wild-type.
| Protein accession number |
| Annotation | Localization |
|---|---|---|---|
| EF3041 | 12.222 | Pheromone binding protein | lipoprotein |
| EF1641 | 3.114 | Iron compound ABC transporter, iron compound binding protein | lipoprotein |
| EF1534 | 2.870 | Peptidyl prolyl cis/trans isomerase | lipoprotein |
| EF3198 | 2.258 | Lipoprotein. YaeC family | lipoprotein |
| EF1354 | 2.230 | Pyruvate dehydrogenase complex. E1 component. beta subunit | cytoplasmic |
| EF1353 | 2.207 | Pyruvate dehydrogenase complex. E1 component. alpha subunit | cytoplasmic |
| EF2191 | 1.983 | dTDP-4-dehydrorhamnose reductase | cytoplasmic |
| EF3082 | 1.955 | Iron compound ABC transporter. substrate binding protein | lipoprotein |
| EF1111 | 1.842 | Signal peptidase I | cell membrane |
| EF1212 | 1.828 | Transcriptional regulator LytR | cell membrane |
| EF2156 | 1.813 | Uncharacterized protein | extracellular |
| EF3062 | 1.768 | Cell shape determining protein MreC | extracellular |
| EF3120 | 1.740 | Serine threonine protein kinase | cytoplasmic |
| EF3037 | 1.602 | Glutamyl aminopeptidase | cytoplasmic |
| EF1677 | 1.601 | Lipoprotein. putative | lipoprotein |
| EF1340 | 1.562 | Pheromone cAM373 lipoprotein | lipoprotein |
| EF1191 | 1.526 | DegV family protein | cytoplasmic |
| EF1759 | 1.491 | Phosphate ABC transporter. phosphate binding protein | lipoprotein |
| EF3027 | 1.420 | Serine protease DO | cell membrane |
| EF1523 | 1.324 | Conserved domainl protein | cytoplasmic |
| EF2656 | 1.315 | Flavoprotein family protein | cytoplasmic |
| EF0176 | 1.300 | Basic membrane protein family | lipoprotein |
| EF1416 | 1.201 | Glucose-6-phosphate isomerase | cytoplasmic |
| EF2697 | 1.159 | Conserved domain protein | cell membrane |
| EF1753 | 1.141 | Uncharacterized protein | cytoplasmic |
| EF1045 | 1.111 | 6-phosphofructokinase | cytoplasmic |
| EF0761 | 1.097 | Amino acid ABC transporter. amino acid binding permease protein | cell membrane |
| EF2496 | 1.085 | Lipoprotein | lipoprotein |
| EF0685 | 1.082 | Foldase protein PrsA | cell membrane |
| EF0784 | 1.079 | S-adenosylmethionine synthase | cytoplasmic |
| EF0949 | 1.040 | Phosphotransacetylase | cytoplasmic |
| EF2608 | 0.904 | ATP synthase subunit beta | cytoplasmic |
| EF2610 | 0.903 | ATP synthase subunit alpha | cytoplasmic |
| EF0863 | 0.887 | Glycine betaine carnitine choline ABC transporter. glycine betaine carnitine choline binding protein | lipoprotein |
| EF2609 | 0.794 | ATP synthase gamma chain | cytoplasmic |
| EF1355 | 0.793 | Pyruvate dehydrogenase complex E2 component. dihydrolipoamide acetyltransferase | cytoplasmic |
| EF3255 | 0.637 | Thiamin biosynthesis lipoprotein ApbE. putative | lipoprotein |
| EF1961 | 0.478 | Enolase | cytoplasmic |
| EF2549 | 0.473 | Uracil phosphoribosyltransferase | cytoplasmic |
| EF2903 | 0.190 | ABC transporter. substrate binding protein | lipoprotein |
| EF3256 | -0.569 | Pheromone cAD1 lipoprotein | lipoprotein |
| EF1548 | -0.577 | Ribosomal protein S1 | cytoplasmic |
| EF1402 | -0.580 | Conserved domain protein | cytoplasmic |
| EF1193 | -0.592 | DNA binding response regulator VicR | cytoplasmic |
| EF2932 | -0.600 | AhpC TSA family protein | cytoplasmic |
| EF1584 | -0.607 | Cysteine synthase | cytoplasmic |
| EF0997 | -0.696 | Cell division protein FtsZ | cytoplasmic |
| EF1138 | -0.871 | Oxidoreductase. aldo-keto reductase family | cytoplasmic |
| EF2355 | -0.934 | Chaperone protein ClpB | cytoplasmic |
| EF1744 | -0.956 | General stress protein. putative | extracellular |
| EF1963 | -0.992 | Phosphoglycerate kinase | cytoplasmic |
| EF1560 | -1.012 | Uncharacterized protein | cytoplasmic |
| EF3054 | -1.051 | Lipoprotein. putative | lipoprotein |
| EF0944 | -1.059 | protein. putative | extracellular |
| EF0715 | -1.107 | Trigger factor | cytoplasmic |
| EF1522 | -1.118 | RNA polymerase sigma factor RpoD | cytoplasmic |
| EF1764 | -1.171 | Ribosomal subunit interface protein | cytoplasmic |
| EF3230 | -1.174 | 30S ribosomal protein S9 | cytoplasmic |
| EF2607 | -1.236 | ATP synthase epsilon chain | cytoplasmic |
| EF2397 | -1.314 | Elongation factor Ts | cytoplasmic |
| EF0228 | -1.380 | Adenylate kinase | cytoplasmic |
| EF2612 | -1.382 | ATP synthase subunit b | cytoplasmic |
| EF2866 | -1.384 | Probable transcriptional regulatory protein | cytoplasmic |
| EF0671 | -1.412 | Xaa-his dipeptidase | cytoplasmic |
| EF0287 | -1.442 | Elongation factor P | cytoplasmic |
| EF2718 | -1.468 | 50S ribosomal protein L1 | cytoplasmic |
| EF0453 | -1.605 | mC-Ohr family protein | cell membrane |
| EF0105 | -1.613 | Ornithine carbamoyltransferase. catabolic | cytoplasmic |
| EF0770 | -1.628 | Uncharacterized protein | cytoplasmic |
| EF0020 | -1.639 | PTS system. mannose specific IIAB components | cytoplasmic |
| EF2715 | -1.642 | 50S ribosomal protein L7 L12 | cytoplasmic |
| EF2729 | -1.689 | Transcription termination antitermination protein nusG | cytoplasmic |
| EF0709 | -1.708 | Phosphocarrier protein HPr | cytoplasmic |
| EF2415 | -1.738 | Uncharacterized protein | cytoplasmic |
| EF0220 | -1.846 | 30S ribosomal protein S8 | cytoplasmic |
| EF2719 | -1.847 | 50S ribosomal protein L11 | cytoplasmic |
| EF0079 | -1.896 | Gls24 protein | cytoplasmic |
| EF0820 | -1.993 | 50S ribosomal protein L25 | cytoplasmic |
| EF2552 | -2.036 | Sua5 YciO YrdC YwlC family protein | cytoplasmic |
| EF2395 | -2.093 | Ribosome recycling factor | cytoplasmic |
| EF0394 | -2.117 | Secreted antigen. putative | extracellular |
| EF1307 | -2.132 | Protein GrpE | cytoplasmic |
| EF0012 | -2.132 | 50S ribosomal protein L9 | cytoplasmic |
| EF0080 | -2.160 | Gls24 protein | cytoplasmic |
| EF2925 | -2.233 | Cold shock domain family protein | cytoplasmic |
| EF2633 | -2.306 | 60 kDa chaperonin | cytoplasmic |
| EF1308 | -2.341 | Chaperone protein DnaK | cytoplasmic |
| EF0466 | -2.345 | Glucosamine-6-phosphate deaminase | cytoplasmic |
a Transmembrane domains were predicted with the TMHMM 2.0 algorithm [53]. Lipoproteins were classified according to Reffuveille et al. [36]. For prediction of cell wall, cytoplasmatic and extracellular proteins Locate P was used (http://www.cmbi.ru.nl/locatep-db/cgi-bin/locatepdb.py). For detailed data see S1 Table.
Fig 1Altered proteins in ΔbgsA classified according to subproteomes by bioinformatic identification.
Proteins significantly downregulated in ΔbgsA compared to E. faecalis 12030 wild type (A). Upregulated proteins in ΔbgsA compared to the wild-type (B). Transmembrane domains were predicted with the TMHMM 2.0 algorithm [53]. Lipoproteins were classified according to Reffuveille et al. [36]. For prediction of cell wall, cytoplasmic and extracellular proteins Locate P was used (http://www.cmbi.ru.nl/locatep-db/cgi-bin/locatepdb.py).
Fig 2Induction of TNF-α in RAW 264.7 mouse macrophages by E. faecalis strains.
Macrophages were stimulated with live and heat-fixed bacteria at multiplicities of infection (MOI) as indicated (A and B) or with cell-free, dialyzed E. faecalis supernatants (C). RAW 264.7 macrophages were seeded at a density of 1 x 105 cells/ml in 24-well dishes in endotoxin-free DMEM containing 10% fetal calf serum. Cultures were stimulated at 37°C in a 5% humidified CO2 environment for 3 h (A) and 16 h (B), respectively, and supernatant from macrophage culture was analyzed for TNF-α by ELISA. The strains used for stimulation are indicated in the legend. LPS was used as positive control. Data represent mean ± SEM of triplicates. ND = not detected. * p < 0.001 12030 ΔbgsA versus 12030 WT, ** p < 0.001 12030 ΔbgsA versus 12030 ΔbgsB, p < 0.001 12030 ΔbgsB versus 12030 WT. § p < 0.001 12030 wild type versus 12030 Δlgt, $ p < 0.001 12030 ΔbgsA versus 12030 ΔbgsA_lgt, & p < 0.001 12030 ΔbgsB versus 12030 ΔbgsB_lgt. Results were compared by 2-way ANOVA with Bonferroni post-test for pairwise comparisons.
Fig 3Stimulation of TNF-α production in RAW 264.7 mouse macrophages by lipoprotein-enriched cell membrane fractions of E. faecalis wild type and ΔbgsA.
RAW 264.7 cells were incubated with lipoprotein-enriched Triton X-114 extracts from total membrane protein fractions derived from the indicated E. faecalis strains. The concentration of lipoprotein extracts was measured photometrically and normalized to a bacterial cfu:RAW 264.7 cell ratio of 10,000:1. At 16 h, supernatants were collected and TNF-α concentrations were quantified by ELISA. LPS at a concentration of 100 ng/ml was used as positive control. Data represent mean ± SEM of triplicates. * p < 0.001 12030 ΔbgsA versus 12030 WT.
Fig 4Stimulation of HEK-TLR2 cells transfected with an NF-κB-dependent ELAM-luciferase reporter gene with E. faecalis antigens.
HEK cells were stimulated for 6 h with escalating antigen concentrations as indicated, lysed and luciferase activity was determined by luminometry. The concentration of bacterial cells is expressed as dry weight per ml. Fold-induction denotes stimulated versus non-stimulated luciferase activity. Stimulation with whole bacterial cells (A). Stimulation with dialyzed cell-free culture supernatant (B). Stimulation with E. faecalis cell membrane total lipid extracts (C). Data are expressed as mean ± SEM of triplicates. ND = not detected. * p < 0.001 12030 ΔbgsA versus 12030 WT, ** p < 0.001 12030 ΔbgsA versus 12030 ΔbgsB, p < 0.001 12030 ΔbgsB versus 12030 wild type by 2-way ANOVA with Bonferroni post-test for pairwise comparisons.
Fig 5Survival and bacterial load of BALB/c mice after intraperitoneal infection with E. faecalis strains.
Survival after infection with 1.3 x 109 E. faecalis. P = 0.0096 EF 12030 wild-type vs. ΔbgsA determined by the log-rank test (A). Bacterial counts 3 h and 12 h after i.p. challenge (inoculum 2.0 x 109 cfu per mouse, 14 mice per group). The bacterial load is expressed as the log10 (cfu) per ml ± SEM (B). P > 0.05 EF 12030 wild-type vs. ΔbgsA vs. ΔbgsB at 3 h and 12 h by 2-way ANOVA.
Fig 6Leukocyte count and TNF-α expression in the PLF 1, 3, and 12 h after intraperitoneal infection with E. faecalis strains.
Number of leukocytes in the PLF (A). TNF-α in the PLF (B). * p < 0.05, ** p < 0.001, by 2-way ANOVA. Data represent means ± SEM of individual mice (8 mice per group).
Fig 7Inflammatory cytokines/chemokines in the plasma 1 h after intraperitoneal infection with E. faecalis strains.
* p < 0.05, ** p < 0.001, by 2-way ANOVA. Data represent means ± SEM of individual cytokine levels of 8 mice.